Skip to main content
OpenTrials
Completed

NCT Number: NCT02701569

Effect of Rebound Exercise in Individuals With Type 2 Diabetes

The purpose of this study was to investigate the effect of rebound exercise (mini trampoline jumping) on metabolic outcomes and quality of life in patients with Type 2 Diabetes.

Completed

Looking for future studies?

Notify Me

Key information

Age range

30 year–60 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

About this study

The exercise involved jumping on the mini trampoline with feet slightly apart. Participants stood on the mid portion of the trampoline bed and made repeated up-and-down bouncy movements. Each foot strike equals one step or bounce. With each landing, the mat of the trampoline underwent deformation and the springs released the energy stored in them such that the participant was made to bounce off the mat. Exercise was administered for between 10 - 15 minutes after which a 5-minute period of rest was allowed. A heart rate monitor was used to guide the intensity of the exercise in the moderate range. Each participant accumulated between 20 and 30 minutes of rebound exercise (bouncing on a mini trampoline) per session, administered three times per week for 12 weeks. All data were captured at baseline and at the end of the 12-week intervention period.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • 30- to 60-year-old male and female individuals;
  • A diagnosis of type 2 diabetes ≤ 5 years;
  • Attendance at the Diabetes Outpatient Clinics of Aminu Kano Teaching Hospital and Murtala Muhammad Specialist Hospital in Kano, Northwestern Nigeria;
  • Self-ambulatory;
  • An inactive lifestyle over the last year.

Exclusion criteria

  • A diagnosis of type 2 diabetes for more than 5 years;
  • Hypertension (systolic and diastolic blood pressure more than 140 and 90 mmHg, respectively) or treatment for hypertension;
  • Use of insulin therapy
  • Lower limb weakness and/or deformities with loss of protective sensation in the feet;
  • Back, shoulder or knee problems and/or joint instability;
  • History of coronary artery disease, retinopathy and nephropathy;
  • Myocardial infarction, cardiac or abdominal surgery within the previous 6 months;
  • History of fractures of the spine, hip, knee and/or ankle joints.

Treatment and study plan

Rebound exercise

Other

Repeated jumping on a mini trampoline was administered

Other names: Mini trampoline rebounding

Primary outcomes

  1. Glycated hemoglobin

    Time frame: 3 months

    Glycated hemoglobin was assessed using the mini-column ion-exchange chromatographic method and expressed in percentage

Secondary outcomes

  1. Fasting plasma glucose

    Time frame: 3 months

    Fasting plasma glucose (in molar concentration) was measured by glucose oxidase assay using a glucose analyzer

  2. Fasting insulin

    Time frame: 3 months

    Fasting insulin (in gravimetric unit) was determined using a commercially available ELISA human insulin kit

  3. High-density lipoprotein cholesterol

    Time frame: 3 months

    High-density lipoprotein cholesterol (in molar concentration) was enzymatically determined using commercial kits

  4. Total cholesterol

    Time frame: 3 months

    Total cholesterol (in molar concentration) was enzymatically determined using commercial kits

  5. Triglycerides

    Time frame: 3 months

    Triglycerides (in molar concentration) were enzymatically determined using commercial kits

  6. Low-density lipoprotein cholesterol

    Time frame: 3 months

    Low-density lipoprotein cholesterol (in molar concentration) was estimated using the Friedewald formula.

  7. Quality of life

    Time frame: 3 months

    The short-form 36 health questionnaire was used to assess participants' quality of life and expressed in percentage

  8. Body mass

    Time frame: 3 months

    Body mass in kilograms was determined using a calibrated weighing scale

  9. Height

    Time frame: 3 months

    Height in meters was determined using a stadiometer

  10. Heart rate

    Time frame: 3 months

    Heart rate was measured in beats per minute using a calibrated electronic device

  11. Respiratory rate

    Time frame: 3 months

    Respiratory rate (in cycles per minute) was measured by observing and counting the number of times the chest rose in one minute

  12. Blood pressure

    Time frame: 3 months

    Blood pressure in millimeters of mercury (mmHg) was measured using a calibrated electronic device

  13. Maximal oxygen consumption

    Time frame: 3 months

    Maximal oxygen consumption in milliliters per kilogram per minute (ml/kg/min) was obtained from exercise stress testing

  14. Diabetes-related emotional distress as measured by the Problem Areas in Diabetes Scale

    Time frame: 3 months

    Diabetes-related emotional distress was expressed in percentage

  15. Well-Being as measured by the World Health Organization-Well-Being Index

    Time frame: 3 months

    Participants' well-being was expressed in percentage

  16. Treatment satisfaction as measured by the World Health Organization-Diabetes Treatment Satisfaction Questionnaire

    Time frame: 3 months

    Score ranges from 0 (very dissatisfied) to 36 (very satisfied)

Other outcomes

  1. Depressive symptoms as measured by the Beck's Depression Inventory

    Time frame: 3 months

    Score ranges from 0 to 63 with 0 to 13 being minimal and 29 to 63 being severe

Sponsors and collaborators

Lead sponsor

University of KwaZulu

Other

Collaborators

  • Aminu Kano Teaching Hospital

Registry information

Official study title

Effect of Rebound Therapy on Metabolic Outcomes and Quality of Life in Nigerian Patients With Type 2 Diabetes

Important dates

Study start
2014
Primary completion
2015
Study completion
2015
First posted
Mar 8, 2016
Registry last updated
Oct 27, 2016

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.